|
CAREC ALERTNovember 2, 2001 Update on the anthrax situation and anthrax guidelinesThe anthrax situation in the Caribbean As of November 1, 2001 CAREC has received five letters containing white powder for anthrax testing, three from Trinidad and Tobago and two from Guyana. Four of these powders tested negative for anthrax and test results are pending for one of the letters from Guyana. CAREC also received five highly suspicious sealed envelopes for anthrax testing, four from Trinidad and Tobago and one from the British Virgin Islands. None of these letters were found to contain any powder. The anthrax situation in the United States As of October 31, 2001 CDC reported 21 cases of anthrax, 16 confirmed (10 inhalation and 6 cutaneous) and 5 suspected cutaneous cases. Four of the 10 confirmed inhalation anthrax cases died. These cases were reported from media houses, among postal or hospital workers or were consistent with exposures to letters known to be contaminated with anthrax spores. The reports were from Washington DC, New Jersey, New York and Florida. The global anthrax situation As of November 1, 2001, while there have been many hoaxes and reported letters and packages with powders, there have not been any confirmed cases of anthrax reported in any country besides the United States. An update of the Carec anthrax guidelines Given the continuing global threat of biological terrorism with anthrax, all countries must have a coordinated comprehensive preparedness plan and response protocols to deal with these threats. This plan must include informing the public of who to contact should they receive:
This plan must also clearly state who is responsible for:
Your preparedness plan must address the following scenarios:
Someone reports receiving an unopened suspicious letter or package If someone reports receiving an unopened suspicious letter or package they should be advised as recommended in the CAREC Information Sheet for the Public – How to handle Anthrax Threats:
There is no need for evacuation or medical treatment in this situation. Someone reports receiving and opening a suspicious letter or package, which was found not to contain powder If someone reports receiving and opening a suspicious letter or package which was found not to contain powder they should be advised that the risk of anthrax infection is highly unlikely for anyone, including the person who opened the letter or package. There is no need for treatment, decontamination or surveillance. Someone reports receiving and opening a suspicious letter or package, which was found to contain powder If someone reports receiving and opening a suspicious letter or package which was found to contain powder they should be advised as recommended in the CAREC Information Sheet for the Public – How to handle Anthrax Threats:
In this situation, persons who were exposed should be given prophylaxis as recommended in the CAREC Anthrax Fact sheet for Physicians and monitored daily for symptoms of anthrax infection. The letter or package with the powder should be delivered to the laboratory in your country that is responsible for receiving possible anthrax samples, as outlined in your preparedness plan.
If laboratory results are negative for anthrax, antibiotics and surveillance should be stopped immediately and decontamination is not necessary. If laboratory results are positive for anthrax, the full course of antibiotics should be administered and daily monitoring should be continued as recommended in the CAREC Anthrax Fact Sheet for Physicians. Please note that both doxycycline and ciprofloxacin are recommended for prophylaxis. Anthrax is also sensitive to amoxicillin, chloramphenicol, clindamycin, tetracycline, rifampin, vancomycin and penicillin. However, the use of penicillin only is not recommended. It will also be necessary to decontaminate the environment where the exposure occurred. |
|
Caribbean Epidemiology Centre Page last modified 16 November, 2001 |